$XPO

XPO Non-GAAP EPS of $1.70 beats by $0.13, revenue of $2.37B misses by $10M (XPO:NYSE)

XPO reported Q3 Non-GAAP EPS of $1.70, beating estimates by $0.13, while revenue of $2.37B missed by $10M. North American LTL revenue grew 17.4% to $1.473B, with adjusted operating income up 35.0% to $293M. According to the company.

Original reporting
Published Oct 29, 2026, 10:50 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$XPO
Neutral
high confidence
Mentioned
$XPO
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$XPONeutralMed
01

Why it matters

The earnings surprise may trigger short‑term buying, but analysts will watch guidance for next quarter.

02

Market read

Earnings release provides fresh data for traders; modest price move expected.

03

What to watch

Potential impact of freight rate volatility and macro‑economic headwinds on future quarters.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

XPO Logistics released its Q3 2026 earnings, reporting a Non‑GAAP EPS beat and a marginal revenue miss.

Company-level read

Ticker impact

$XPONeutralHigh confidence
Context

Q3 Non‑GAAP EPS of $1.70 beats expectations by $0.13; revenue of $2.37 B misses by $10 M.

Expected impact

modest upside pressure as market prices in the EPS beat, with potential headroom limited by revenue miss

Evidence & confidence

The EPS surprise is material for a mid‑cap logistics firm, while the revenue shortfall is small; traders may take a short‑term long position.

Market effects

Logistics and transportation sector may see modest re‑rating as earnings data rolls through.

U.S. equity markets may see a small bump in transportation stocks.

Limited; primarily U.S. investors focused on XPO.

Counterpoint

Revenue miss could signal slowing demand, suggesting caution despite EPS beat.

Key entities

  • XPO Logistics

    U.S. listed logistics provider (ticker XPO).

Related articles

$XPOMed

What XPO (XPO) Said on Its Q3 Earnings Call

XPO reported Q3 volume growth and pricing improvements, driven by service quality and higher-margin freight. The company expanded its fleet and network capacity, targeting local accounts and AI-driven operations. Costs increased due to inflation and higher fuel prices, but insourcing efforts reduced outsourced miles. XPO generated $291M in free cash flow, repurchased $150M in stock, and expects to double free cash flow by 2026.

$XPOHighAI 8/10

Stifel raises XPO stock price target to $235 on strong execution

Stifel raised its XPO (NYSE:XPO) price target to $235, citing strong Q3 2026 execution, margin expansion, and EPS of $1.70. XPO's operating ratio improved 260 bps YoY. Analysts revised earnings upwards, though the stock trades above Fair Value. Revenue was slightly below expectations at $2.37B. Other analysts adjusted targets, with UBS at $232 and Jefferies at $275.

$XPOMed

UBS lowers XPO stock price target on valuation to $232 from $257

UBS reduced its price target for XPO (NYSE:XPO) to $232 from $257, citing valuation concerns. The stock is currently trading at $183.01. XPO reported Q3 2026 earnings, beating EPS estimates but missing on revenue. The company showed revenue growth and improved margins, leading to optimistic full-year guidance. Analysts from Jefferies and Raymond James maintained positive ratings with adjusted price targets.

$XPOMed

Raymond James raises XPO stock price target on LTL pricing momentum

Raymond James raised its price target for XPO (NYSE:XPO) to $210, citing momentum in LTL pricing and operational improvements. The stock trades at $183.01, with a potential 15% upside. XPO reported Q3 2026 earnings beating EPS estimates but missing revenue targets, while Jefferies maintained a Buy rating with a $275 target. The company showed margin and cash flow improvements, and yield growth accelerated to 5% in October.

$XPOMed

XPO Inc (XPO) Q3 2026 Earnings Call Highlights: Record LTL Margins, Accelerating Pricing

XPO Inc. reported Q3 2026 earnings, highlighting record LTL margins and accelerating pricing. The company expects Q4 operating ratio (OR) below 82%, improving year-over-year. Full-year OR improvement is now guided at 250 bps or better. October tonnage grew mid-6% year-over-year, accelerating from September. XPO plans to double free cash flow to near $800 million in 2026, funding share buybacks and debt paydown. The company is considering selling its European operations to focus on North America.